Live Vaccine Laringo Vak

Infectious laryngotracheitis (ILT) in poultry is a highly contagious respiratory disease that can cause mass mortality and sharp drops in productivity, leading to serious economic losses for a farm. The live Laringo Vak vaccine from Zoetis is specifically designed for reliable prevention of this infection in both commercial and breeding poultry operations.

The vaccine is based on the highly immunogenic attenuated “Salsbury 146” strain, grown on clean SPF embryos, ensuring high concentration and exceptional stability. It induces a strong immune response within 14 days after administration, providing long-lasting protection for at least 6 months.

A key advantage for large poultry farms is the flexibility of mass vaccination methods: the vaccine can be administered enterally (via drinking water), by coarse spray (spray method), or individually via ocular route. This allows easy integration into any scale of production without causing stress to the flock.

Implementing Laringo Vak in your farm’s veterinary program is a strategic step to strengthen biosecurity. By protecting the flock’s respiratory system, you prevent sudden disease outbreaks, reduce emergency treatment costs, and ensure uninterrupted production cycles. It is a reliable solution for maintaining poultry health and ensuring high farm profitability.